
Electromed ELMD
$ 23.89
1.19%
Quarterly report 2025-Q4
added 02-10-2026
Electromed Accounts Receivables 2011-2026 | ELMD
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Electromed
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.7 M | 23.3 M | 24.1 M | 21.1 M | 17 M | 12.9 M | 12.8 M | 11.6 M | 9.95 M | 7.61 M | 6.52 M | 6.49 M | 9.01 M | 10.9 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.7 M | 6.49 M | 14.1 M |
Quarterly Accounts Receivables Electromed
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.3 M | 24.8 M | 24.7 M | 23.4 M | 22.8 M | 22.4 M | 23.3 M | 23.9 M | 23 M | 23.5 M | 24.1 M | 22.3 M | 21.6 M | 21 M | 21.1 M | 19.6 M | 19.1 M | 18.4 M | 17 M | 17 M | 15.4 M | 13.6 M | 12.9 M | 12.9 M | 12.7 M | 12.7 M | 12.8 M | 12.8 M | 11.9 M | 11.5 M | 11.8 M | 11.8 M | 9.68 M | 9.64 M | 9.95 M | 9.95 M | 8.28 M | 8.04 M | 7.61 M | 7.61 M | 6.9 M | 6.46 M | 6.52 M | 6.52 M | 6.63 M | 6.36 M | 6.49 M | 6.49 M | 7.04 M | 7.99 M | 9.01 M | 9.01 M | 9.73 M | 10.4 M | 10.9 M | 10.9 M | 10.7 M | 10.4 M | 9.59 M | 9.59 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 26.3 M | 6.36 M | 13.8 M |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
11.4 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
371 M | $ 12.04 | -0.25 % | $ 1.63 B | ||
|
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
6.55 M | $ 9.18 | -2.13 % | $ 260 M | ||
|
Bruker Corporation
BRKR
|
566 M | $ 36.66 | -0.22 % | $ 5.46 K | ||
|
Apollo Endosurgery
APEN
|
15 M | - | - | $ 475 M | ||
|
OrthoPediatrics Corp.
KIDS
|
53.8 M | $ 15.85 | -0.6 % | $ 372 M | ||
|
EDAP TMS S.A.
EDAP
|
17.9 M | $ 3.42 | -1.16 % | $ 128 M | ||
|
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
996 M | $ 169.13 | -1.6 % | $ 12.7 B | ||
|
AxoGen
AXGN
|
26.2 M | $ 31.12 | -4.66 % | $ 1.43 B | ||
|
Axonics Modulation Technologies
AXNX
|
44.8 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
1.73 M | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
20.8 M | $ 4.05 | -2.29 % | $ 857 M | ||
|
Cytosorbents Corporation
CTSO
|
7.55 M | $ 0.61 | 3.37 % | $ 38 M | ||
|
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
11.7 M | $ 9.77 | 0.72 % | $ 350 M | ||
|
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | ||
|
Alphatec Holdings
ATEC
|
97.3 M | $ 11.14 | 1.55 % | $ 1.67 B | ||
|
CONMED Corporation
CNMD
|
248 M | $ 34.58 | 1.51 % | $ 1.07 B | ||
|
Globus Medical
GMED
|
679 M | $ 90.41 | 2.01 % | $ 12.2 B | ||
|
Edwards Lifesciences Corporation
EW
|
660 M | $ 81.03 | -0.15 % | $ 47.4 B | ||
|
Helius Medical Technologies
HSDT
|
117 K | $ 1.81 | -4.74 % | $ 1.1 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
272 M | $ 9.29 | -0.21 % | $ 715 M | ||
|
Inspire Medical Systems
INSP
|
120 M | $ 54.5 | 0.69 % | $ 1.6 B | ||
|
IRIDEX Corporation
IRIX
|
7.61 M | $ 1.05 | 4.86 % | $ 17.8 M | ||
|
Integer Holdings Corporation
ITGR
|
346 M | $ 85.84 | 0.26 % | $ 2.98 B | ||
|
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M | ||
|
LENSAR
LNSR
|
6.38 M | $ 5.78 | -1.95 % | $ 69.1 M | ||
|
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | ||
|
Medtronic PLC
MDT
|
6.52 B | $ 86.74 | 0.52 % | $ 112 B | ||
|
Cutera
CUTR
|
43.1 M | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
2.8 M | - | 14.99 % | $ 929 K | ||
|
Myomo
MYO
|
4.1 M | $ 0.67 | -4.8 % | $ 28 M | ||
|
Eargo
EAR
|
1.91 M | - | - | $ 10.2 M | ||
|
Second Sight Medical Products
EYES
|
455 K | - | -0.97 % | $ 54.4 M | ||
|
Orthofix Medical
OFIX
|
136 M | $ 11.85 | 0.64 % | $ 469 M |